Biolife Sciences (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 24-05-2024
- Paid Up Capital ₹ 0.10 M
as on 24-05-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 68.90%
(FY 2022)
- Ebitda 96.00%
(FY 2022)
- Net Worth -8.22%
(FY 2022)
- Total Assets -0.71%
(FY 2022)
About Biolife Sciences (Opc)
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sweety Yadav and Sunit Kumar serve as directors at the Company.
- CIN/LLPIN
U74999DL2020OPC370536
- Company No.
370536
- Incorporation Date
26 Sep 2020
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Biolife Sciences (Opc)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunit Kumar  | Additional Director | 07-Apr-2023 | Current |
| Sweety Yadav | Director | 26-Sep-2020 | Current |
Financial Performance of Biolife Sciences (Opc).
Biolife Sciences (Opc) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 68.9% increase in profit. The company's net worth dipped by a decrease of 8.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biolife Sciences (Opc)?
Unlock access to Biolife Sciences (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biolife Sciences Impex Private LimitedActive 1 year 5 monthsSweety Yadav and Sunit Kumar are mutual person
- Spurt Pharmaceuticals Private LimitedActive 16 years 5 months
Sweety Yadav and Sunit Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biolife Sciences (Opc)?
Biolife Sciences (Opc) has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biolife Sciences (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biolife Sciences (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
